RxDoctor Payments DataLook up a doctor →

Mudassir Nawaz, MD

Internal Medicine · Norman, OKNPI 1396737789

Payments from drug & device makers

$10,322in general payments, 2019–2025

Across 623 payments — averaging $16.57 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Lilly USA, LLC$1K
  • GSK$1K
  • Amgen$903
  • AstraZeneca$856
  • Pfizer$777
  • Novo Nordisk$593
  • plus $5K from 38 others

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Lilly USA, LLC91$1,207
GSK84$1,173
Amgen50$903
AstraZeneca(2 entities)46$856
Pfizer49$777
Novo Nordisk35$593
Mylan Specialty L.p.34$577
AbbVie(2 entities)25$451
Novartis20$391
Boehringer Ingelheim18$358
Bayer16$341
Merck19$248
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC14$234
Abbott10$197
Dexcom, Inc.8$146
E.r. Squibb & Sons, L.L.C.8$139
Sanofi-aventis U.S. LLC9$138
Inogen, Inc.12$131
Exact Sciences7$126
Teva Pharmaceuticals USA, Inc.8$114
Astellas Pharma US Inc5$114
Axsome Therapeutics, Inc.4$104
Sumitomo Pharma America, Inc.4$100
Baxter Healthcare4$90
Johnson & Johnson5$84
Xeris Pharmaceuticals, Inc.4$78
Viatris Specialty LLC3$64
Verona Pharma, Inc.4$62
Lundbeck LLC3$55
Sunovion Pharmaceuticals Inc.3$55
Eisai Inc.2$51
Ultragenyx Pharmaceutical Inc.2$43
Amarin Pharma, Inc.2$37
Corcept Therapeutics1$33
Radius Health, Inc.2$33
Bardy Diagnostics, Inc.2$33
Insulet Corporation2$31
Antares Pharma, Inc.2$31
Almatica Pharma LLC1$26
Inspire Medical Systems, Inc.1$25
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)1$21
Philips North America LLC1$19
Idorsia Pharmaceuticals US Inc1$19
Currax Pharmaceuticals LLC1$13

How this compares

$10,322 in reported general payments places this provider in the 90th percentile of 840 internal medicine providers in Oklahoma.

See all internal medicine providers in Oklahoma →

Medicare billing

Part B allowed, 2024
$319,509
Medicare patients
422
Services billed
3,633

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other internal medicine in Norman

See the full list for Oklahoma →

Where these figures come from

Is this you, or does something look wrong? →